Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen

R. Dgani, Y. Zalel, H. Biran, I. Blickstein, B. Caspi, A. Weissman, Z. Shoham

Research output: Contribution to journalArticlepeer-review

Abstract

A 29-year-old nullipara with partial hydatidiform mole at 8 weeks had pre-evacuation hCG levels of 275 000 mIU/ml. Free beta-hCG levels were measured as 3%(normal value below 4%). The patient developed persistent gestational trophoblastic disease, failed to respond to methotrexate and actinomycin D, but has responded to combination chemotherapy with EMA-CO. Such a response to EMA-CO was not reported previously.

Original languageEnglish
Pages (from-to)77-79
Number of pages3
JournalEuropean Journal of Obstetrics, Gynecology and Reproductive Biology
Volume54
Issue number1
DOIs
StatePublished - 31 Mar 1994
Externally publishedYes

Keywords

  • Combination chemotherapy
  • Partial mole
  • Persistent gestational trophoblastic disease

Fingerprint

Dive into the research topics of 'Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen'. Together they form a unique fingerprint.

Cite this